cell culture, bioinformatics, cancer
How Kidney Cancer Evolves
How Kidney Cancer Evolves
Jim Daley | Apr 18, 2018
Renal cell carcinoma tumors have three different evolutionary fates, each associated with specific clinical outcomes.
Immune Therapy Improves Lung Cancer Patients’ Survival
Immune Therapy Improves Lung Cancer Patients’ Survival
Jim Daley | Apr 17, 2018
Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.
Antibody Combo Expands Response to Checkpoint Inhibitor in Mice
Antibody Combo Expands Response to Checkpoint Inhibitor in Mice
Kerry Grens | Apr 16, 2018
Genetic analyses uncover cellular hallmarks of bladder cancer tumors that don’t respond, but interfering with one of those characteristics in a mouse model causes tumors to shrink.  
Birth Defects Linked to Increased Risk of Childhood Cancer
Birth Defects Linked to Increased Risk of Childhood Cancer
Jim Daley | Apr 15, 2018
Certain non-chromosomal defects are strongly associated with specific childhood cancers.
Wound-Healing in Mice Triggers Growth of Dormant Tumors
Wound-Healing in Mice Triggers Growth of Dormant Tumors
Jim Daley | Apr 12, 2018
Treating mice with anti-inflammatory drugs following surgery reduced the size of tumors.
Image of the Day: Tumor Organoids
Image of the Day: Tumor Organoids
The Scientist Staff | Apr 11, 2018
Miniature versions of bladder cancers could help physicians identify personalized treatment options for patients.
Human Cancer Drugs May Be Effective in Tasmanian Devils
Human Cancer Drugs May Be Effective in Tasmanian Devils
Shawna Williams | Apr 9, 2018
A new study reveals similarities between the transmissible cancers that infect the endangered marsupials, and hints at ways to treat them.
Hundreds of Inherited Gene Variants Contribute to Cancer
Hundreds of Inherited Gene Variants Contribute to Cancer
Abby Olena | Apr 5, 2018
In the largest study of its kind to date, researchers find more than 850 rare, heritable genetic alterations that can predispose humans to cancer.
OSU Professor Falsified Data on Eight Papers, Resigns
OSU Professor Falsified Data on Eight Papers, Resigns
Catherine Offord | Apr 2, 2018
Ching-Shih Chen’s research involved anticancer therapeutics that were being tested in clinical trials.
Contributors
Contributors
The Scientist Staff | Apr 1, 2018
Meet some of the people featured in the April 2018 issue of The Scientist.